COMMUNIQUÉS West-GlobeNewswire

-
SELLAS Life Sciences Announces Pricing of Upsized $24.2 Million Public Offering
12/07/2018 -
Marrone Bio Innovations to Host Virtual Roadshow Webinar on July 26th, 2018
12/07/2018 -
Cutera, Inc. to Announce Second Quarter 2018 Results
12/07/2018 -
Avinger Announces Pricing of $3.55 Million Registered Direct Offering
12/07/2018 -
Tauriga Sciences, Inc. on Track to Up-List its Shares to OTCQB Exchange at Open of Trading on July 30, 2018
12/07/2018 -
WishBone Medical, Inc. announces Sanford S. Kunkel, M.D. joins Board of Advisors
12/07/2018 -
Catalyst Biosciences Announces Multiple Presentations at the Scientific and Standardization Committee Meeting of the International Society on Thrombosis and Haemostasis
12/07/2018 -
Altimmune Restructures Financing Agreement with Majority of the Remaining Series B Investors
12/07/2018 -
CLS Holdings USA Provides an Update to the First Complete Year of Adult Use Cannabis in Nevada
12/07/2018 -
Sirona Biochem Announces CFDA Approval of SGLT2 Inhibitor for Phase I Clinical Trial
12/07/2018 -
Cue Biopharma Produces Immuno-STAT™ Biologic Candidate for Treatment of Autoimmune Disease Under Collaboration and License Agreement with Merck
12/07/2018 -
HCi Viocare Rebrands Itself and Becomes Rafina Innovations Inc.
12/07/2018 -
Managers' transactions
12/07/2018 -
Zynerba Pharmaceuticals Announces New FAB-C Phase 2 Open-Label Data in Patients with Fragile X Syndrome
12/07/2018 -
Asterias Biotherapeutics Announces New Exclusive License Agreement with The Regents of the University of California for Stroke IP; Second Pre-Clinical Collaboration Initiated to Test the Efficacy of AST-OPC1 for the Treatment of Stroke
12/07/2018 -
Xenon Pharmaceuticals Announces At-The-Market Equity Offering
12/07/2018 -
Allergy Therapeutics PLC: Trading Update
12/07/2018 -
ProQR Announces Presentations on Programs in Ophthalmology at Conferences in July
12/07/2018 -
Microbix to Present at Okanagan Capital Conference
12/07/2018
Pages